The Nomogram prediction of 1-year, 2-year, 3-year and 5-year overall survival in TCGA CRC patients also showed that higher MSI2 expression was associated with a better prognosis (Fig. 7N). The gene discussed is MSI2; the disease is colorectal carcinoma.